BeStock  
Markets › Compare › QDEL vs CTKB

QDEL vs CTKB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
QDEL · QuidelOrtho$8.32 ▼ 6.73%
CTKB · Cytek Biosciences$6.12 ▼ 3.16%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

255482111139Nov 24, '25May 26, '26Nov 20, '26
  • QDEL -68.7%
  • CTKB +4.8%

Head to head

MetricQDELCTKB
Price$8.32$6.12
Change today▼ 6.73%▼ 3.16%
Market cap$570.86M$800.40M
Return, 3 months-42.6%+37.8%
Return, year to date-70.9%+21.2%
Return, 1 year-65.8%+4.1%
P/E (TTM)––
P/B0.32.5
P/E percentile vs own 5y31st70th
Dividend yield––
Revenue growth (YoY, latest qtr)-11.6%+1.8%
Net profit growth (YoY)+92.7%-11.3%
Gross margin44.2%54.7%
Operating margin-2.6%-21.1%
Net margin-14.2%-39.1%
Return on equity-19.3%-23.2%
Analyst target vs. price+44.2%+18.5%
Analyst buy share50%100%
RSI (14)2957
30-day volatility99.7%58.9%
Max drawdown, 1 year-76.5%-42.9%
Trend readStrong downtrendStrong uptrend
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CTKB is the largest of the group by market value.
  • CTKB has returned the most over the past year.
  • CTKB is growing revenue fastest.
  • QDEL keeps the most profit per dollar of sales.
  • CTKB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top